" class="no-js "lang="en-US"> Healx Archives - Medtech Alert
Thursday, March 28, 2024

Sort by:

Date

Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Healx and Ovid Therapeutics Enter Strategic Partnership

Ovid Therapeutics (NASDAQ:OVID) (“Ovid”), a biopharmaceutical company committed to developing medicines that transform the lives of […]

Healx Receives IND and Orphan Drug Designation for Fragile X Clinical Trial

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, is proud […]

Healx Launches AI-powered Indication Expansion Partnership with Ono Pharmaceutical Co. Ltd.

Healx, the AI-powered, patient-inspired technology company pioneering the next generation of drug discovery, today announced […]

Healx Using Artificial Intelligence to Find Combination Drug Treatments for Covid-19

Healx, the AI-powered, patient-inspired biotech specialising in rare diseases, today announces it is using its […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more